PMEL and melanoma: In a melanoma mouse model, the altered long-peptide gp10025–33 vaccine together with the TLR7 ligand imiquimod (to activate gp100-specific CTL responses), and the mAb TA99 (specific for the melanocyte protein TRP-1) were used in combination (90).